好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Results from the CATZ Study: A Phase III, Double-Blind, Randomized, Placebo-Controlled Trial To Assess the Efficacy and Safety of Adjunctive Zonisamide in Pediatric Patients with Partial-Onset Seizures
Epilepsy
(-)
100
Authors/Disclosures
Anna Rosati, MD (C/o Clinica Neurologica) No disclosure on file
Robert L. Carruthers, MD Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
No disclosure on file
Luigi Giorgi, MD No disclosure on file
Renzo Guerrini (Hotelplan) Renzo Guerrini has nothing to disclose.